Cancer EVs can also promote the activation of quiescent fibroblasts to cancer-associated fibroblasts (CAFs) via the transfer of growth factors, such as the transforming growth factor β (TGFβ), miRNAs, or mutant p53. This evidence concerns the gene TP53 and cancer.